Going after infectious diseases? We’re with you.
Infections can have various sources and affect most of the human organs. FGK has a diversified range of experience in the development of anti-infectives including anti-bacterials, anti-virals and anti-fungals. Also vaccine and other preventive approaches are part of our portfolio.
Therapeutic approaches include:
- COVID-19
- Chronic hepatitis C virus (HCV) infection of various geotypes (HCV)
- Hepatitis B infection
- HIV
- H5N1 (avian flu)
- Human papilloma virus infection (HPV)
- MRSA
- Local and systemic fungal infections
- Pneumonia (community acquired / hospital acquired)
- Sexually transmitted disease (STD)
- Wound healing
- Disturbances, or acute and chronic wound infection
Dr. Ralf Amann, Group Leader at the Institute of Immunology
University Hospital Tübingen
In our investigator-initiated study, FGK did far more than perform standard tasks. They engaged as thinking partners, proposing and discussing fit-for-purpose approaches, while remaining highly reliable and responsive. Clear, timely communication between our teams facilitated coordination and problem-solving throughout, contributing directly to smoother operations and higher study quality.
If you’re interested in our broad experience across managing the complexity of modern trial design, get in touch with us.
